| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 01/15/2009 | WO2009006990A2 Minor splicosome assay system for modulating cell division |
| 01/15/2009 | WO2009006905A1 Dehydrated chitosan nanoparticles |
| 01/15/2009 | WO2009006782A1 CLONING TRANSCRIPTION FACTOR GENE OsWOX20 THAT REGULATES THE GROWTH AND DEVELOPMENT OF MONOCOTYLEDON'S ROOT AND USES THEREOF |
| 01/15/2009 | WO2009006743A1 Nucleic acid sequences and combination thereof for sensitive amplification and detection of bacterial and fungal sepsis pathogens |
| 01/15/2009 | WO2009006700A1 Immunology treatment for biofilms |
| 01/15/2009 | WO2008146019A3 Method for baculovirus generation from insect cells in high-troughput plates |
| 01/15/2009 | WO2008144580A3 Primate stem cells produced by somatic cell nuclear transfer |
| 01/15/2009 | WO2008144473A3 Chimeric pufa polyketide synthase systems and uses thereof |
| 01/15/2009 | WO2008142318A3 Genes encoding z,z-farnesyl diphosphate synthase and a sesquiterpene synthase with multiple products and uses thereof |
| 01/15/2009 | WO2008140415A9 H5 subtype-specific binding proteins useful for h5 avian influenza diagnosis and surveillance |
| 01/15/2009 | WO2008135113A8 Expression system used for the antibiotic-free production of polypeptides |
| 01/15/2009 | WO2008127997A9 Enhanced protein expression using auto-induction media |
| 01/15/2009 | WO2008124166A3 Fusion proteins of collagen-binding domain and parathyroid hormone |
| 01/15/2009 | WO2008121953A3 Interferon produced in plastids |
| 01/15/2009 | WO2008121154A3 Nucleic acid sequences for biosynthesis of non -mccj25-related lariat peptides |
| 01/15/2009 | WO2008113983A3 Cancer cell specific promoter comprising nf-kappa b binding sites |
| 01/15/2009 | WO2008112970A3 Dominant gene suppression transgenes and methods of using same |
| 01/15/2009 | WO2008109544A9 Nucleic acid compounds for inhibiting muc1 gene expression and uses thereof |
| 01/15/2009 | WO2008109532A4 Nucleic acid compounds for inhibiting fas gene expression and uses thereof |
| 01/15/2009 | WO2008109500A4 Nucleic acid compounds for inhibiting prkca gene expression and uses thereof |
| 01/15/2009 | WO2008109470A4 Nucleic acid compounds for inhibiting ptpn1 gene expression and uses thereof |
| 01/15/2009 | WO2008109460A9 Nucleic acid compounds for inhibiting ctnnb1 gene expression and uses thereof |
| 01/15/2009 | WO2008109373A9 Nucleic acid compounds for inhibiting erbb gene expression and uses thereof |
| 01/15/2009 | WO2008108660A3 Fish disease detection |
| 01/15/2009 | WO2008105890A3 Chloroplast transit peptides for efficient targeting of dmo and uses thereof |
| 01/15/2009 | WO2008097854A4 Method and substances for treating hpv infection |
| 01/15/2009 | WO2008089193A3 Human erythrovirus |
| 01/15/2009 | WO2008089073A3 Combinatorial libraries of conformationally constrained polypeptide sequences |
| 01/15/2009 | WO2008088582A9 Methods and materials related to trail isoforms |
| 01/15/2009 | WO2008087208A3 Maize plants characterised by quantitative trait loci (qtl) |
| 01/15/2009 | WO2008087141A3 Use of subtilisin (rnr9) polynucleotides for achieving a pathogen resistance in plants |
| 01/15/2009 | WO2008085951A3 Treatment of tumors by ablating bone marrow-derived endothelial progenitor cells |
| 01/15/2009 | WO2008067547A3 Improved immunoglobulin libraries |
| 01/15/2009 | WO2008035291A3 A double stranded rna oligonucleotide: a pharmaceutical or cosmetic composition containing it and its use as an active pharmaceutical ingredient in the treatment of androgen-related diseases |
| 01/15/2009 | WO2008017598A3 Citrusal aroma receptors and use of myrac aldehyde derivatives for increasing the flagellation frequency of a spermatozoon |
| 01/15/2009 | WO2007101602A9 Chimeric kunitz domains and their use |
| 01/15/2009 | WO2007070501A3 A vaccination method |
| 01/15/2009 | WO2006073202A9 METHOD OF TUMOR SUPPRESSION AND EVALUATION OF ANTICANCER AGENT BASED ON GSK3β INHIBITORY EFFECT |
| 01/15/2009 | WO2005080580A3 Use of the myb4 transcriptional factor from rice to increase the production of secondary metabolites by transformed plants |
| 01/15/2009 | US20090019609 Expression of Cry3B Insecticidal Protein in Plants |
| 01/15/2009 | US20090019608 Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same |
| 01/15/2009 | US20090019606 Plants Having Increased Yield And A Method For Making The Same |
| 01/15/2009 | US20090019605 Plant having reduced lignin and cellulose contents without reducing glucan content, method of producing the same and utilization thereof |
| 01/15/2009 | US20090019604 Soybean variety d4203144 |
| 01/15/2009 | US20090019603 Soybean variety d4696658 |
| 01/15/2009 | US20090019602 Master activators of pathogen responsive genes |
| 01/15/2009 | US20090019601 Nucleic acid molecules and other molecules associated with plants and uses thereof for plant improvement |
| 01/15/2009 | US20090019600 Pepper Hybrid 'E 499526' |
| 01/15/2009 | US20090019599 Pepper Hybrid E 499524 |
| 01/15/2009 | US20090019598 Anther specific promoters and uses thereof |
| 01/15/2009 | US20090019596 Inbred sweet corn line r373d |
| 01/15/2009 | US20090019592 Soybean variety d4356652 |
| 01/15/2009 | US20090019591 Soybean variety d4456885 |
| 01/15/2009 | US20090019590 Soybean variety d4698013 |
| 01/15/2009 | US20090019589 Soybean variety d4637114 |
| 01/15/2009 | US20090019588 Soybean variety d4520980 |
| 01/15/2009 | US20090019587 Soybean variety d4521369 |
| 01/15/2009 | US20090019586 Soybean variety d4223057 |
| 01/15/2009 | US20090019585 Soybean variety d4682156 |
| 01/15/2009 | US20090019584 Soybean variety d4233569 |
| 01/15/2009 | US20090019583 Soybean variety d4925614 |
| 01/15/2009 | US20090019582 Soybean variety d4102536 |
| 01/15/2009 | US20090019581 Soybean variety d4865324 |
| 01/15/2009 | US20090019580 Soybean variety d4825495 |
| 01/15/2009 | US20090019579 Soybean variety d4659251 |
| 01/15/2009 | US20090019578 Soybean variety d4258962 |
| 01/15/2009 | US20090019577 Soybean variety d4253969 |
| 01/15/2009 | US20090019576 Soybean variety d4256925 |
| 01/15/2009 | US20090019575 Soybean variety d4253681 |
| 01/15/2009 | US20090019574 Soybean variety d4789254 |
| 01/15/2009 | US20090019573 Soybean variety d4713125 |
| 01/15/2009 | US20090019572 Soybean variety d4526223 |
| 01/15/2009 | US20090019571 Soybean variety d4556201 |
| 01/15/2009 | US20090019570 Soybean variety d4012368 |
| 01/15/2009 | US20090019569 Soybean variety d4452019 |
| 01/15/2009 | US20090019568 Soybean variety d4201483 |
| 01/15/2009 | US20090019567 Soybean variety d4463892 |
| 01/15/2009 | US20090019566 Soybean variety d4159630 |
| 01/15/2009 | US20090019565 Soybean variety d4470236 |
| 01/15/2009 | US20090019564 Soybean variety d4063284 |
| 01/15/2009 | US20090019562 Solanum bulbocastanum polyubiquitin Bul409 promoter and uses thereof |
| 01/15/2009 | US20090019560 Removing ovocyte and placing in proteasome inhibitor solution to prevent activation, transferring nucleus of donor cell, activating and implanting into uterus of recipient; producing animal models |
| 01/15/2009 | US20090019559 Nucleic Acid |
| 01/15/2009 | US20090019555 increased lung mucus retention and its genome comprises a promoter linked to a heterologous DNA encoding an epithelial sodium channel subunit; useful in treatment of bronchitis and asthma; drug screening |
| 01/15/2009 | US20090018321 Methods and compositions for the specific inhibition of gene expression by double-stranded rna |
| 01/15/2009 | US20090018320 Dna detection method using molecular beacon with the use of monomer emission/excimer emission switching of fluorescent molecule |
| 01/15/2009 | US20090018316 Propagating interleukin-15 specific monoclonal antibody for use as tool in controllig immune response |
| 01/15/2009 | US20090018315 B7-H3 and B7-H4, Novel Immunoregulatory Molecules |
| 01/15/2009 | US20090018314 low affinity receptor for IgE (FceRII/CD23); for modulating or inhibiting induced IgE expression; allergic conditions, autoimmune and inflammatory diseases |
| 01/15/2009 | US20090018312 Igf-1 receptor interacting proteins |
| 01/15/2009 | US20090018098 Targeting the absence: homozygous dna deletions as signposts for cancer therapy |
| 01/15/2009 | US20090018097 Modification of double-stranded ribonucleic acid molecules |
| 01/15/2009 | US20090018095 Antigen, nucleic acid encodes fusion protein; polynucleotides; nucleoside sequences |
| 01/15/2009 | US20090018094 Inhibition of brain enzymes involved in cerebral amyloid angiopathy and macular degeneration |
| 01/15/2009 | US20090018083 Methods and compositions for inhibition of bcl6 repression |
| 01/15/2009 | US20090018081 Activatable clostridial toxins |
| 01/15/2009 | US20090018079 Optimized dna and protein sequence of an antibody to improve quality and yield of bacterially expressed antibody fusion proteins |
| 01/15/2009 | US20090018077 Fibroblast Growth Factor-Like Polypeptides |
| 01/15/2009 | US20090018076 Fibroblast Growth Factor-Like Polypeptides |
| 01/15/2009 | US20090018075 Peptides in Inhibiting Insects |